191 related articles for article (PubMed ID: 26869657)
1. Meningeal Myelomatosis.
DeFilipp Z; Sahovic EA; Nooka AK
J Oncol Pract; 2016 Feb; 12(2):187-8. PubMed ID: 26869657
[No Abstract] [Full Text] [Related]
2. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
3. [Meningeal myelomatosis as an exclusive form of recurrence in a case of IgA-lambda myeloma in complete systemic remission].
Estellés Piera F; Gómez Codina J; Munárriz Gandía B; Maestu Maiques I; Montalar Salcedo J
Med Clin (Barc); 1991 Oct; 97(13):503-5. PubMed ID: 1758207
[TBL] [Abstract][Full Text] [Related]
4. Meningeal involvement in multiple myeloma: report of a case with cytologic and immunocytochemical diagnosis.
Cavanna L; Invernizzi R; Berte' R; Vallisa D; Buscarini L
Acta Cytol; 1996; 40(3):571-5. PubMed ID: 8669198
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement.
Tian C; Yang H; Zhu L; Zhang Q; Cao Z; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1407-1410. PubMed ID: 28577043
[No Abstract] [Full Text] [Related]
6. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
7. [Meningeal myelomatosis. Presentation of a case].
Gioseffi ON; Alfonso G; Rosenfeld E; Briend S; Cohen R
Sangre (Barc); 1992 Apr; 37(2):137-9. PubMed ID: 1621184
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
Ali R; Beksac M; Ozkalemkas F; Ozkocaman V; Ozkan A; Ozcelik T; Tunali A
Leuk Lymphoma; 2007 Jul; 48(7):1426-8. PubMed ID: 17613776
[No Abstract] [Full Text] [Related]
9. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience.
Muzaffar J; Usmani S; Abdallah AO; Anaissie E; Cottler-Fox M; Restrepo A
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):171-4. PubMed ID: 23313066
[No Abstract] [Full Text] [Related]
10. [Focal neurological deficits and meningeal myelomatosis].
Vidal JA; Caminal L; Tuñón A; Díaz López B
An Med Interna; 1995 Feb; 12(2):99-100. PubMed ID: 7749021
[No Abstract] [Full Text] [Related]
11. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
[TBL] [Abstract][Full Text] [Related]
12. Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda.
Mohamed ZA; Pelletier S; Vintze-Geoffrion A; Lagacé-Nadon S; Olney HJ; Adam JP
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e264-e266. PubMed ID: 33390349
[No Abstract] [Full Text] [Related]
13. Pleural effusion formation in the course of myeloma.
Comert M; Gursoy S; Tobu M
Arch Bronconeumol; 2015 Aug; 51(8):418-9. PubMed ID: 25619415
[No Abstract] [Full Text] [Related]
14. Meningeal relapse after double peripheral blood stem cell transplantation in IgD myeloma.
Ochiai N; Shimazaki C; Okano A; Hatsuse M; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Nakagawa M
Leuk Lymphoma; 2002 Mar; 43(3):641-3. PubMed ID: 12002772
[TBL] [Abstract][Full Text] [Related]
15. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature.
Petersen SL; Wagner A; Gimsing P
Am J Hematol; 1999 Dec; 62(4):228-33. PubMed ID: 10589078
[TBL] [Abstract][Full Text] [Related]
16. Plasma cell leukemia 3 months after autologous blood cell transplantation for multiple myeloma.
Koskela K; Pelliniemi TT; Lakkala T; Remes K
Bone Marrow Transplant; 1998 Feb; 21(3):305-7. PubMed ID: 9489657
[TBL] [Abstract][Full Text] [Related]
17. CNS myelomatosis.
Lupu VD; Saini N; Balish M
Neurology; 2005 Mar; 64(6):1007. PubMed ID: 15781817
[No Abstract] [Full Text] [Related]
18. Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
Thakral B; Muzzafar T
Blood; 2017 Jul; 130(2):231. PubMed ID: 28705862
[No Abstract] [Full Text] [Related]
19. NCCN: Multiple myeloma.
Traynor AE; Noga SJ;
Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
